Canlyniadau Chwilio - Kate Talks

  • Dangos 1 - 8 canlyniadau o 8
Mireinio'r Canlyniadau
  1. 1
    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival gan Alexandra Giatromanolaki, Michael I. Koukourakis, Efthimios Sivridis, Helen Turley, Kate Talks, Francesco Pezzella, Kevin C. Gatter, Adrian L. Harris

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B gan Rachel Rayment, Elizabeth Chalmers, Katherine E. Law, Richard Gooding, Anne M. Kelly, Susan Shapiro, Kate Talks, Oliver Tunstall, Tina Biss

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp>

    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp> gan Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ian Jennings, Ri Liesner, Savita Rangarajan, Kate Talks, Michael D. Williams, C. R. M. Hay

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Ex... gan Peter W. Collins, Ri Liesner, Michael Makris, Kate Talks, Pratima Chowdary, Elizabeth Chalmers, Georgina Hall, Anne Riddell, Charles Percy, C. R. M. Hay, Daniel P. Hart

    Cyhoeddwyd 2018
    Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia gan Charlotte Bradbury, Julie Pell, Quentin A. Hill, Catherine Bagot, Nichola Cooper, Jenny Ingram, Katie Breheny, Rebecca Kandiyali, Rachel Rayment, Gillian Evans, Kate Talks, Ian Thomas, Rosemary Greenwood

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α

    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α gan Michael S. Wiesener, Helen Turley, William E. Allen, Carsten Willam, Kai‐Uwe Eckardt, Kate Talks, S.M. Wood, Kevin C. Gatter, Adrian L. Harris, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell

    Cyhoeddwyd 1998
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B

    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B gan Pratima Chowdary, Susan Shapiro, Michael Makris, Gillian Evans, Sara Boyce, Kate Talks, Gerard Dolan, Ulrike M. Reiss, Mark Phillips, Anne Riddell, Maria R. Peralta, Michelle Quaye, David Patch, Edward G. D. Tuddenham, Allison Dane, Marie Watissée, Alison Long, Amit C. Nathwani

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study

    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study gan Nichola Cooper, Marie Scully, Charles Percy, Phillip L. R. Nicolson, Gillian Lowe, Catherine Bagot, Jecko Thachil, H. Grech, Tim Nokes, Quentin A. Hill, Charlotte Bradbury, Kate Talks, Tina Dutt, Gillian Evans, Sue Pavord, Sarah Wexler, Asad Charania, Sarah J. Collington, Andrew Ervin, Nicholas Ramscar, Drew Provan

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: